No profile data available.
Lantheus Holdings, Inc. (LNTH) is a healthcare company in the targeted healthcare equipment industry, based in Bedford, United States, with about 1,193 full-time employees.
It reported revenue of $1.54 billion for fiscal year 2025, up 0.5% from fiscal year 2024, and net income of $233.56 million. In Q2 2026 (the quarter ended June 30, 2026) revenue was $388.18 million, up 2.7% from a year before. U.S. was its largest region in fiscal year 2025, with 95% of revenue. Its market capitalization was $6.54 billion as of October 9, 2026.
Figures from company filings and market data; latest fiscal year ended December 31, 2025; market data as of October 9, 2026.
Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in diagnosis and treatment of heart, cancer, and other diseases worldwide.
Lantheus reported $1.54 billion in revenue for fiscal year 2025, up 0.5% from $1.53 billion in fiscal year 2024. In Q2 2026 revenue was $388.18 million.
U.S.: 95% of revenue by region in fiscal year 2025, followed by Rest of world (5%).
$6.54 billion as of October 9, 2026.
Listed companies of a similar size in the same industry (targeted healthcare equipment) include Penumbra, Inc. (PEN), The Cooper Companies, Inc. (COO), Glaukos Corporation (GKOS), Axogen, Inc. (AXGN).